Cargando…

L‐citrulline inhibits body weight gain and hepatic fat accumulation by improving lipid metabolism in a rat nonalcoholic fatty liver disease model

BACKGROUND: Body weight gain is a social issue all over the world. When body weight increased, hepatic fat accumulation also increased and it causes fatty liver disease. Therefore, developing a new treatment method and elucidating its mechanism is necessary. L‐citrulline (L‐Cit) is a free amino acid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kudo, Maya, Yamagishi, Yoshie, Suguro, Shiori, Nishihara, Masaaki, Yoshitomi, Hisae, Hayashi, Misa, Gao, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441368/ https://www.ncbi.nlm.nih.gov/pubmed/34532001 http://dx.doi.org/10.1002/fsn3.2439

Ejemplares similares

L-Citrulline increases hepatic sensitivity to insulin by reducing the phosphorylation of serine 1101 in insulin receptor substrate-1
por: Yoshitomi, Hisae, et al.
Publicado: (2015)

Evaluation of the effect of methionine and glucosamine on adjuvant arthritis in rats
por: YAMAGISHI, YOSHIE, et al.
Publicado: (2012)

Citrulline Accumulation Mechanism of Pediococcus acidilactici and Weissella confusa in Soy Sauce and the Effects of Phenolic Compound on Citrulline Accumulation
por: Zhou, Kai, et al.
Publicado: (2021)

Ectopic Fat Accumulation and Distant Organ-Specific Insulin Resistance in Japanese People with Nonalcoholic Fatty Liver Disease
por: Kato, Ken-ichiro, et al.
Publicado: (2014)

Lipid accumulation product is a predictor of nonalcoholic fatty liver disease in childhood obesity
por: Özcabı, Bahar, et al.
Publicado: (2019)

LY6D is crucial for lipid accumulation and inflammation in nonalcoholic fatty liver disease
por: Lee, Jibeom, et al.
Publicado: (2023)

Madecassoside Inhibits Body Weight Gain via Modulating SIRT1-AMPK Signaling Pathway and Activating Genes Related to Thermogenesis
por: Sun, Boju, et al.
Publicado: (2021)

Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model
por: Xu, Ren-ying, et al.
Publicado: (2012)

Nonalcoholic Fatty Liver Disease and Abdominal Fat Accumulation According to Vitamin D Status in Patients with Type 2 Diabetes
por: Choi, Dug-Hyun, et al.
Publicado: (2018)

Cyclocarya paliurus extract activates insulin signaling via Sirtuin1 in C2C12 myotubes and decreases blood glucose level in mice with impaired insulin secretion
por: Yoshitomi, Hisae, et al.
Publicado: (2017)

Foxa1 Reduces Lipid Accumulation in Human Hepatocytes and Is Down-Regulated in Nonalcoholic Fatty Liver
por: Moya, Marta, et al.
Publicado: (2012)

High Fat Diet with a High Monounsaturated Fatty Acid and Polyunsaturated/Saturated Fatty Acid Ratio Suppresses Body Fat Accumulation and Weight Gain in Obese Hamsters
por: Yang, Suh-Ching, et al.
Publicado: (2017)

Depletion of B cell-activating factor attenuates hepatic fat accumulation in a murine model of nonalcoholic fatty liver disease
por: Nakamura, Yoshiko, et al.
Publicado: (2019)

Nonalcoholic Lipid Accumulation and Hepatocyte Malignant Transformation
por: Gu, Juanjuan, et al.
Publicado: (2016)

The association of pericardial fat and peri-aortic fat with severity of nonalcoholic fatty liver disease
por: Lee, Chun-Wei, et al.
Publicado: (2022)

Guava leaf extracts alleviate fatty liver via expression of adiponectin receptors in SHRSP.Z-Leprfa/Izm rats
por: Yoshitomi, Hisae, et al.
Publicado: (2012)

Ectopic fat deposition and its related abnormalities of lipid metabolism followed by nonalcoholic fatty pancreas
por: Chen, Yan, et al.
Publicado: (2022)

Inhibition of TREM‐1 attenuates inflammation and lipid accumulation in diet‐induced nonalcoholic fatty liver disease
por: Rao, Shenzong, et al.
Publicado: (2019)

Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammation
por: Zhou, Jingxuan, et al.
Publicado: (2022)

Amycenone reduces excess body weight and attenuates hyperlipidaemia by inhibiting lipogenesis and promoting lipolysis and fatty acid β-oxidation in KK-A(y) obese diabetic mice
por: Kudo, Maya, et al.
Publicado: (2022)

Impact of Visceral Fat on the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease
por: Jeong, Seul-Ki, et al.
Publicado: (2008)

Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesis
por: Fang, Miao, et al.
Publicado: (2020)

Icariin Alleviates Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome by Improving Liver Fatty Acid Oxidation and Inhibiting Lipid Accumulation
por: Hai, Yang, et al.
Publicado: (2023)

N-Acetyl Cysteine Ameliorates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease and Intracellular Triglyceride Accumulation by Preserving Mitochondrial Function
por: Hang, Weijian, et al.
Publicado: (2021)

Estimation of Liver Fat by FibroScan in Patients With Nonalcoholic Fatty Liver Disease
por: Shrestha, Rupesh, et al.
Publicado: (2021)

Gypenosides ameliorate high-fat diet-induced nonalcoholic fatty liver disease in mice by regulating lipid metabolism
por: Zhou, Tingting, et al.
Publicado: (2023)

Asprosin contributes to nonalcoholic fatty liver disease through regulating lipid accumulation and inflammatory response via AMPK signaling
por: Zhang, Bo, et al.
Publicado: (2023)

Lipids in the Wrong Place: Visceral Fat and Nonalcoholic Steatohepatitis
por: Perseghin, Gianluca
Publicado: (2011)

Chitosan Oligosaccharide Attenuates Nonalcoholic Fatty Liver Disease Induced by High Fat Diet through Reducing Lipid Accumulation, Inflammation and Oxidative Stress in C57BL/6 Mice
por: Tao, Wenjing, et al.
Publicado: (2019)

Telmisartan improves nonalcoholic steatohepatitis in medaka (Oryzias latipes) by reducing macrophage infiltration and fat accumulation
por: Kuwashiro, Shinya, et al.
Publicado: (2011)

Administration of L-arginine plus L-citrulline or L-citrulline alone successfully retarded endothelial senescence
por: Tsuboi, Tomoe, et al.
Publicado: (2018)

The association of weight gain with nonalcoholic fatty liver disease and fibrosis detected by FibroScan in the United States
por: Wijarnpreecha, Karn, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution
por: Alferink, Louise Johanna Maria, et al.
Publicado: (2019)

An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease
por: Pei, Ke, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease experiences accumulation of hepatic liquid crystal associated with increasing lipophagy
por: Wang, Liyang, et al.
Publicado: (2020)

Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
por: Dongiovanni, P., et al.
Publicado: (2017)

Noninvasive Quantitative Detection Methods of Liver Fat Content in Nonalcoholic Fatty Liver Disease
por: Lv, Shujing, et al.
Publicado: (2018)

Sex-specific contribution of lipid accumulation product and cardiometabolic index in the identification of nonalcoholic fatty liver disease among Chinese adults
por: Liu, Yiting, et al.
Publicado: (2022)

Loss of mitochondrial ATPase ATAD3A contributes to nonalcoholic fatty liver disease through accumulation of lipids and damaged mitochondria
por: Chen, Liting, et al.
Publicado: (2022)

Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis
por: Ebrahimi, Menooa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_568p75eut32bmf9nm8s1ajulae